Autres langues Burning Rock Biotech Limited

Actions

BNR

US12233L2060

Installations et services en soins de santé

Marché Fermé - Nasdaq 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
16,25 ^USD	+1,63 %		-12,63 %	-19,35 %

10/09	Burning Rock Biotech Limited publie ses résultats pour le deuxième trimestre clos le 30 juin 2026	CI
20/07	Burning Rock Biotech Limited et Myriad Genetics annoncent un partenariat mondial de licence technologique stratégique pour étendre les tests HRD à l'international	CI

Autres langues

16/09	Burning Rock Biotech : Presents Three Studies at WCLC 2026, Exploring Precision Lung Cancer Care Across Disease Biology, Treatment Response and Molecular Testing
10/09	Burning Rock Biotech Limited Reports Earnings Results for the Second Quarter Ended June 30, 2026
10/09	Burning Rock Reports Second Quarter 2026 Financial Results
09/09	Burning Rock Biotech : Second WES-Based Personalized MRD Kit Enters NMPA Special Review Procedure for Innovative Medical Devices
25/08	Burning Rock Biotech : WES-Based Personalized MRD Kit Enters NMPA Special Review Procedure for Innovative Medical Devices
20/07	Burning Rock Biotech Limited and Myriad Genetics Announce Global Strategic Technology Licensing Partnership to Expand Hrd Testing Worldwide
02/07	Burning Rock Biotech Insider Bought Shares Worth $6,182,172, According to a Recent SEC Filing
02/07	Burning Rock Announces Founder’s Purchase of Its ADSs
09/06	Burning Rock Reports First Quarter 2026 Financial Results
09/06	Burning Rock Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2026
28/04	Burning Rock Publishes 2025 Annual Report on Form 20-F
13/04	Aurelion Inc. Announces Executive Changes, Effective April 13, 2026
02/04	Burning Rock Biotech Insider Bought Shares Worth $5,466,143, According to a Recent SEC Filing
02/04	Burning Rock Announces Founder’s Purchase of Its ADSs
13/03	Burning Rock Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
12/03	Burning Rock Biotech : Fourth Quarter 2025 Presentation Slides
12/03	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results
26/01	Burning Rock Biotech : Milestone in Precision Oncology! Burning Rock Dx’s Breast Cancer NGS CDx Kit Enters the CMDE Priority Review Channel
06/01	Burning Rock Biotech : Liquid Biopsy Technology Granted U.S. Patent, Accelerating Global Layout in Precision Diagnosis
05/01	Burning Rock Announces Founder’s Purchase of Its ADSs
23/12	Burning Rock Announces Results of 2025 Annual General Meeting
18/12	From Accreditation to Excellence: Webinar Highlights on CAP, CLIA, and Quality Systems in Clinical Laboratories
01/12	Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025
01/12	Burning Rock Biotech : BR - 2025 AGM - Notice of AGM (cfb8ff)
20/11	Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025